相关实验视频

Updated: Jul 10, 2026

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Orthotopic Implantation and Peripheral Immune Cell Monitoring in the II-45 Syngeneic Rat Mesothelioma Model

Published on: October 2, 2015

抗美索林CAR-NK细胞作为一种针对宫癌的新型向疗法

Ivana Kutle¹, Robert Polten¹, Jan Lennart Stalp^1,2

¹Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.

Frontiers in immunology

|January 9, 2025

概括

化学抗原受体 (CAR) - - 向美索林的NK细胞在晚期子宫癌中表现有前途. 这些工程NK细胞有效地杀死癌细胞并增强化疗结果,提供了一种新的治疗途径.

科学领域:

免疫治疗是一种免疫疗法.
在瘤学瘤学.
细胞疗法细胞疗法

背景情况:

晚期子宫癌由于治疗耐药性,结果不佳.
化学抗原受体 (CAR) -NK细胞疗法对液体癌症有希望,但在宫癌中尚未探索.

研究的目的:

开发和评估用于宫癌治疗的抗美索林CAR-NK细胞.
评估这些工程NK细胞对表达美索林的宫癌的疗效和特异性.

主要方法:

工程自然杀手 (NK) 细胞与第三代抗美索林CAR使用alpharetroviral SIN载体.
在2D和3D模型中对宫癌细胞系进行了细胞毒性和脱粒测试.
利用CRISPR-Cas9生成美索林阴性细胞进行特异性测试和组合疗法实验.

主要成果:

抗美索林CAR-NK细胞对宫癌细胞表现出显著的细胞毒性.
在暴露于美索林阳性点细胞时,CAR-NK细胞脱粒化增加.
使用梅索林淘汰细胞证实了特异性;组合疗法增强了癌细胞的消除.

结论:

抗美索林CAR-NK细胞表现出强大的抗瘤活性,对抗宫癌.
这种方法显示出作为一种新型治疗美索林阳性宫癌和其他恶性瘤的潜力.

关键词:

在CAR-NK细胞中.在CAR-T细胞中.梅索他林是其中一种蛋白质.宫癌:子宫癌是一种癌症.化学疗法化疗化疗嵌合式抗原受体 (CAR) 是一种免疫疗法免疫疗法

更多相关视频

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.